Organon & Co. (OGN) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
OGN Revenue Growth
Revenue Breakdown
OGN's revenue distribution by segment and geography
By Geography
OGN Revenue Analysis (2018–2025)
As of May 8, 2026, Organon & Co. (OGN) generated trailing twelve-month (TTM) revenue of $6.22 billion, reflecting moderate decline in growth of -5.3% year-over-year. The most recent quarter (Q4 2025) recorded $1.51 billion in revenue, down 5.9% sequentially.
Looking at the longer-term picture, OGN's 5-year compound annual growth rate (CAGR) stands at -1.0%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $9.78 billion in 2018.
When compared to Healthcare sector peers including PFE (+1.4% YoY), VTRS (+1.6% YoY), and ABBV (+8.6% YoY), OGN has underperformed the peer group in terms of revenue growth. Compare OGN vs PFE →
OGN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| OGNCurrent | $6.2B | -5.3% | -1.0% | 20.7% | |
 PFE | $62.6B | +1.4% | +8.5% | 24.7% | |
 VTRS | $14.3B | +1.6% | +3.7% | -18.6% | |
 ABBV | $61.2B | +8.6% | +6.0% | 32.8% | |
 HLN | $10.8B | +10.7% | +1.7% | 22.4% | |
 TEVA | $17.3B | +4.4% | +0.7% | 12.5% |
OGN Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.22B | -2.9% | $3.36B | 54.1% | $1.28B | 20.7% |
| 2024 | $6.40B | +2.2% | $3.71B | 58.0% | $1.49B | 23.2% |
| 2023 | $6.26B | +1.4% | $3.75B | 59.8% | $1.33B | 21.2% |
| 2022 | $6.17B | -2.1% | $3.88B | 62.8% | $1.71B | 27.6% |
| 2021 | $6.30B | -3.5% | $3.92B | 62.2% | $1.92B | 30.4% |
| 2020 | $6.53B | -16.0% | $4.41B | 67.6% | $2.85B | 43.6% |
| 2019 | $7.78B | -20.5% | $5.50B | 70.8% | $3.85B | 49.5% |
| 2018 | $9.78B | - | $5.08B | 52.0% | $2.71B | 27.7% |
See OGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOGN — Frequently Asked Questions
Quick answers to the most common questions about buying OGN stock.
Is OGN's revenue growth accelerating or slowing?
OGN revenue declined -5.3% year-over-year, contrasting with the 5-year CAGR of -1.0%. TTM revenue fell to $6.2B. This reverses the prior growth trend.
What is OGN's long-term revenue growth rate?
Organon & Co.'s 5-year revenue CAGR of -1.0% reflects the variable expansion pattern. Current YoY growth of -5.3% is below this long-term average.
How is OGN's revenue distributed by segment?
OGN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.